Which of the following drugs is not used in the treatment of mycobacterium avium intracellular infection?
**Core Concept**
The treatment of Mycobacterium avium intracellulare (MAC) infection involves a combination of antibiotics to target the intracellular pathogens. The drugs used must be able to penetrate into host cells and inhibit bacterial growth.
**Why the Correct Answer is Right**
The primary treatment for MAC infection includes macrolides, such as clarithromycin, and rifamycin derivatives, like rifabutin. Ethambutol and fluoroquinolones are also used in combination therapy. However, trimethoprim-sulfamethoxazole is not a standard treatment for MAC infection.
**Why Each Wrong Option is Incorrect**
**Option A:** Clarithromycin is a macrolide antibiotic used in the treatment of MAC infection due to its ability to penetrate into host cells and inhibit bacterial protein synthesis.
**Option B:** Rifabutin is a rifamycin derivative that plays a crucial role in the treatment of MAC infection by inhibiting bacterial DNA synthesis.
**Option C:** Ethambutol is a first-line agent in the treatment of MAC infection, which works by inhibiting the synthesis of the bacterial cell wall.
**Option D:** Trimethoprim-sulfamethoxazole is primarily used in the treatment of other types of bacterial infections, such as Pneumocystis jirovecii pneumonia, and is not a standard treatment for MAC infection.
**Clinical Pearl / High-Yield Fact**
MAC infection often occurs in immunocompromised individuals, such as those with HIV/AIDS, and requires a combination of antibiotics to effectively treat the infection.
**Correct Answer:** D. Trimethoprim-sulfamethoxazole.